Article info
PDFRheumatoid arthritis
Infections in baricitinib clinical trials for patients with active rheumatoid arthritis
- Correspondence to Dr Kevin L Winthrop, Oregon Health and Science University, Portland, OR 97201, USA; winthrop{at}ohsu.edu
Citation
Infections in baricitinib clinical trials for patients with active rheumatoid arthritis
Publication history
- Received December 17, 2019
- Revised April 29, 2020
- Accepted May 13, 2020
- First published August 11, 2020.
Online issue publication
September 14, 2020
Article Versions
- Previous version (11 August 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.